Why Choose the Evidence MultiSTAT?
-
World’s most diverse test menu facilitating on-site simultaneous screening of multiple drug classes, comprising over 500 drugs and drug metabolites.
-
Simple 2 step process from sample entry to results, offering efficient and accurate screening.
-
Panels are available across multiple matrices with as little as 200μl sample volume required, ensuring more sample is available for confirmatory testing.
-
Qualitative results are provided in <20 minutes offering an efficient and accurate screen.
-
The Evidence MultiSTAT has proven accurate test results with CVs typically <10% with a 98% agreement with confirmatory methods.
-
Multiplex testing delivers a fast and cost effective solution compared to traditional methods.
The Evidence MultiSTAT is a fully automated immunoanalyser that enables on-site simultaneous detection of up to 44 analytes from a single sample of oral fluid, urine or blood. It requires a small sample volume and generates results in less than 20 minutes. The process from sample entry to results can be completed in 2 simple steps, with minimum room for human error. The process is designed to make set up and analysis as quick, simple and reliable as possible.
The MultiSTAT offers a very simple screening solution to those who have no knowledge of laboratory procedures through combining simplicity with cutting-edge innovation. It is this innovative technology that enables the MultiSTAT to be easy to use, yet extremely powerful.
The Evidence MultiSTAT
Meet the Evidence MultiSTAT
The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers, drugs and drug metabolites.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
As minimal sample preparation is required, qualitative results are provided in less than 20 minutes offering efficient and accurate screening.
Meet the Cartridge
The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.
Evidence MultiSTAT Test Menu
| Assay | Cut Off | Assay | Cut Off |
| Fentanyl | 2 ng/ml | TCA | 150 ng/ml |
| Ethyl Glucuronide (EtG) | 750 ng/ml | Cannabinoids (THC) | 20 ng/ml |
| Methamphetamine | 200 ng/ml | Amphetamine | 200 ng/ml |
| Barbiturates | 200 ng/ml | Buprenorphine | 1 ng/ml |
| Benzodiazepines I | 150 ng/ml | 6-MAM | 10 ng/ml |
| Benzodiazepines II | 150 ng/ml | Synthetic Cannabinoids (JWH-018) | 20 ng/ml |
| Methadone | 300 ng/ml | α-PVP | 5 ng/ml |
| Opiates | 200 ng/ml | Synthetic Cannabinoids (UR-144) | 10 ng/ml |
| BZG (Cocaine Metabolite) | 150 ng/ml | AB-PINACA | 2.5 ng/ml |
| Oxycodone | 50 ng/ml | Creatinine* | 20 mg/dl |
| Tramadol | 5 ng/ml | * Urine Adulteration Marker |
| Assay | Cut Off | Assay | Cut Off |
| Fentanyl | 1 ng/ml | BZG (Cocaine Metabolite) | 25 ng/ml |
| AB-PINACA | 2 ng/ml | Oxycodone | 10 ng/ml |
| Ethyl Glucuronide (EtG) | 500 ng/ml | Tramadol | 5 ng/ml |
| Methamphetamine | 50 ng/ml | Cannabinoids (THC) | 10 ng/ml |
| Barbiturates | 50 ng/ml | Tricyclic Antidepressants (TCA) | 60 ng/ml |
| Benzodiazepines | 20 ng/ml | Amphetamine | 50 ng/ml |
| AB-CHMINACA | 5 ng/ml | Buprenorphine | 2 ng/ml |
| Methadone | 10 ng/ml | 6-MAM | 10 ng/ml |
| Opiates | 80 ng/ml | α-PVP | 5 ng/ml |
| Phencyclidine (PCP) | 5 ng/ml | Pregabalin | 1000 ng/ml |
| Assay | Cut Off | Assay | Cut Off |
| Fentanyl | 1 ng/ml | Cannabinoids (THC) | 2 ng/ml |
| Ketamine | 50 ng/ml | Amphetamine | 50 ng/ml |
| LSD | 1 ng/ml | Buprenorphine | 1 ng/ml |
| Methamphetamine | 50 ng/ml | 6-MAM | 2 ng/ml |
| Barbiturates | 50 ng/ml | Synthetic Cannabinoids (JWH-018) | 5 ng/ml |
| Benzodiazepines I | 10 ng/ml | alpha-PVP | 2 ng/ml |
| Benzodiazepines II | 10 ng/ml | Synthetic Cannabinoids (UR-144) | 10 ng/ml |
| Methadone | 4 ng/ml | BZG/Cocaine | 20 ng/ml |
| Opiates | 10 ng/ml | Oxycodone | 8 ng/ml |
| PCP | 5 ng/ml | Tramadol | 4 ng/ml |
| Glutathione S- Transferase Pi (GSTP1) | Parkinson Disease Protein 7 (PARK7) | Nucleoside Diphosphate Kinase A (NDKA) |
| Glutathione S- Transferase Pi (GSTP1) | Parkinson Disease Protein 7 (PARK7) | Nucleoside Diphosphate Kinase A (NDKA) |
| Glial Fibrillary Acidic Protein (GFAP) | Fatty Acid Binding Protein 3 (FABP3) | Interleukin 6 (IL-6) |
| 6-MAM | Acetaminophen |
| Amphetamine | Barbiturates |
| Benzoylecgonine (BZG) | Buprenorphine |
| Cannabinoids (THC) | Clonazepam |
| Creatinine (Urine Only) | Dextromethorphan |
| Ethyl Glucuronide (EtG) | Fentanyl |
| Haloperidol | Ketamine |
| MDMA | Meprobamate |
| Methadone | Methamphetamine |
| Methaqualone | Opiate |
| Oxazepam | Oxycodone |
| Phencyclidine (PCP) | Pregabalin |
| Propoxyphene | Salicylate |
| Tramadol | Tricyclic Antidepressants (TCA) |
| Zolpidem |
| Assay | Cut Off | Assay | Cut Off |
| IL-1beta | 1.71 pg/ml | MCP-1 | 11.03 pg/ml |
| IL-2 | 9.83 pg/ml | IL-15 | 9.46 pg/ml |
| IL-6 | 2.87 pg/ml | Ferritin | 7.42 ng/ml |
| IFNgamma | 10.4 pg/ml | D-dimer | 35.34 ng/ml 0 |
| TNFalpha | 20.11 pg/ml |